Citation Impact
Citing Papers
Gender Disparity in Liver Cancer Due to Sex Differences in MyD88-Dependent IL-6 Production
2007 StandoutScience
Update on prevention, diagnosis, and treatment of chronic hepatitis B: AASLD 2018 hepatitis B guidance
2018 Standout
CRISPR/Cas9 cleavage of viral DNA efficiently suppresses hepatitis B virus
2015 StandoutNatureNobel
HBV cccDNA: viral persistence reservoir and key obstacle for a cure of chronic hepatitis B
2015
Coinfection of hepatitis B and C viruses and risk of hepatocellular carcinoma: Systematic review and meta‐analysis
2010
Targeting Hepatitis B Virus With CRISPR/Cas9
2014
Chronic hepatitis B in children after e antigen seroclearance: Final report of a 29-year longitudinal study
2006
Genetic Polymorphisms and the Progression of Liver Fibrosis: A Critical Appraisal
2003
Methylation Regulates Hepatitis B Viral Protein Expression
2009
Occult hepatitis B infection and HBV replicative activity in patients with cryptogenic cause of hepatocellular carcinoma
2011
HBV and HIV Coinfection and Liver Transplant
2010
Diagnostic and predictive factors of significant liver fibrosis and minimal lesions in patients with persistent unexplained elevated transaminases. A prospective multicenter study
2006
Liver fibrosis
2005 Standout
Control of cccDNA function in hepatitis B virus infection
2009
Hepatocellular carcinoma, human immunodeficiency virus and viral hepatitis in the HAART era
2008
Chronic Venous Disease
2006 Standout
A robust cell culture system supporting the complete life cycle of hepatitis B virus
2017 StandoutNobel
Experimental models and therapeutic approaches for HBV
2012
Regulation of microRNA biogenesis
2014 Standout
Hepatitis B virus reactivation associated with antirheumatic therapy: Risk and prophylaxis recommendations
2015
Hemochromatosis C282Y gene mutation increases the risk of venous leg ulceration
2005
Exploring the virome of diseased horses
2015
Global burden of NAFLD and NASH: trends, predictions, risk factors and prevention
2017 Standout
AAV-Mediated Delivery of Zinc Finger Nucleases Targeting Hepatitis B Virus Inhibits Active Replication
2014
Significance of hepatitis virus infection in the oncogenic initiation of hepatocellular carcinoma
2016
New insight in the pathobiology of hepatitis B virus infection
2012
Multiple Hepatitis B Virus (HBV) Quasispecies and Immune-Escape Mutations Are Present in HBV Surface Antigen and Reverse Transcriptase of Patients With Acute Hepatitis B
2016
Focus on hepatocellular carcinoma
2004
Hepatitis B surface antigen seroclearance during nucleoside analogue therapy: surface antigen kinetics, outcomes, and durability
2015
Targeting hepatitis B virus cccDNA by CRISPR/Cas9 nuclease efficiently inhibits viral replication
2015
Hepatocellular carcinoma
2012 Standout
Improved rolling circle amplification (RCA) of hepatitis B virus (HBV) relaxed-circular serum DNA (RC-DNA)
2013
Immunology of hepatitis B virus and hepatitis C virus infection
2005 Standout
Hepatitis B virus infection
2009 Standout
Association between occult hepatitis B infection and the risk of hepatocellular carcinoma: a meta‐analysis
2011
The role of quantitative hepatitis B surface antigen revisited
2016
An Efficient Antiviral Strategy for Targeting Hepatitis B Virus Genome Using Transcription Activator-Like Effector Nucleases
2013
Hepatitis due to Reactivation of Hepatitis B Virus in Endemic Areas Among Patients With Hepatitis C Treated With Direct-acting Antiviral Agents
2016
Hepatocellular carcinoma: Recent trends in Japan
2004
Diagnosis and Treatment of Polycystic Ovary Syndrome: An Endocrine Society Clinical Practice Guideline
2013 Standout
Management of Hepatocellular Carcinoma: An Update Δσ
2011 Standout
Management of Hepatocellular Carcinoma *
2005 Standout
Viral hepatitis and liver cancer: the case of hepatitis C
2006
Molecular biology of hepatitis B virus infection
2015
Hepatitis B virus-induced oncogenesis
2007
HBsAg variants: Diagnostic-escape and diagnostic dilemma
2012
Mechanisms of HBV-induced hepatocellular carcinoma
2016
Hepatocellular carcinoma in cirrhosis: Incidence and risk factors
2004 Standout
Expanded classification of hepatitis C virus into 7 genotypes and 67 subtypes: Updated criteria and genotype assignment web resource
2013 StandoutNobel
A Broad RNA Virus Survey Reveals Both miRNA Dependence and Functional Sequestration
2016 StandoutNobel
Evaluation of risk factors in the development of hepatocellular carcinoma in autoimmune hepatitis: Implications for follow-up and screening
2008
Reactivation of DNA viruses in association with histone deacetylase inhibitor therapy: a case series report
2009
Chronic hepatitis B
2007 Standout
Recognition of Conserved Amino Acid Motifs of Common Viruses and Its Role in Autoimmunity
2005 StandoutNobel
The dsRNA protein kinase PKR: Virus and cell control
2007
Attacking hepatitis B virus cccDNA – The holy grail to hepatitis B cure
2016
Chronic hepatitis B: Update 2009 #
2009 Standout
MicroRNAs Associated With HBV Infection And HBV-related HCC
2014
Epidemiology of Viral Hepatitis and Hepatocellular Carcinoma
2012 Standout
Mechanism-driven biomarkers to guide immune checkpoint blockade in cancer therapy
2016 Standout
Lymphoproliferative Disease and Hepatitis B Reactivation: Challenges in the Era of Rapidly Evolving Targeted Therapy
2015
Applications of CRISPR technologies in research and beyond
2016 StandoutNobel
CRISPR/Cas9 cleavage of viral DNA efficiently suppresses hepatitis B virus
2015 StandoutNobel
Lymphocytes transiently expressing virus-specific T cell receptors reduce hepatitis B virus infection
2017
Paradoxical roles of the immune system during cancer development
2006 Standout
Occult hepatitis B virus infection
2006
Incidence and Predictors of Hepatocellular Carcinoma in Patients With Cirrhosis
2007
Immune cell responses are not required to induce substantial hepatitis B virus antigen decline during pegylated interferon-alpha administration
2013
Late HDV RNA Relapse After Peginterferon Alpha-Based Therapy of Chronic Hepatitis Delta
2014
Long-term hepatitis B infection in a scalable hepatic co-culture system
2017
Hepatitis B virus and hepatitis C virus dual infection
2014
Adaptive immunity in HBV infection
2016
Long-term clinical and histological outcomes in patients with spontaneous hepatitis B surface antigen seroclearance
2004
Targeting the Achilles heel of the hepatitis B virus: a review of current treatments against covalently closed circular DNA
2015 StandoutNobel
NF-κB functions as a tumour promoter in inflammation-associated cancer
2004 StandoutNature
Pathogenesis of hepatitis B virus—related hepatocellular carcinoma: Old and new paradigms
2004
Antiviral CD8-mediated responses in chronic HCV carriers with HBV superinfection
2004
Naturally occurring deletion/insertion mutations within HBV whole genome sequences in HBeAg-positive chronic hepatitis B patients are correlated with baseline serum HBsAg and HBeAg levels and might predict a shorter interval to HBeAg loss and seroconversion during antiviral treatment
2015
Replicative Activity of Hepatitis B Virus Is Negatively Associated with Methylation of Covalently Closed Circular DNA in Advanced Hepatitis B Virus Infection
2011
Low Risk of Hepatitis B Virus Reactivation in HBsAg-negative/Anti-HBc–positive Carriers Receiving Rituximab for Rheumatoid Arthritis: A Retrospective Multicenter Italian Study
2016
Hepatocellular Carcinoma
2011 Standout
Matrix Crosslinking Forces Tumor Progression by Enhancing Integrin Signaling
2009 Standout
The way forward in HCV treatment — finding the right path
2007 StandoutNobel
Effects of amino acid substitutions in hepatitis B virus surface protein on virion secretion, antigenicity, HBsAg and viral DNA
2016 StandoutNobel
A set of reference sequences for the hepatitis C genotypes 4d, 4f, and 4k covering the full open reading frame
2008
Biogenesis of small RNAs in animals
2009 Standout
The Emerging Role of In Vitro-Transcribed mRNA in Adoptive T Cell Immunotherapy
2019 StandoutNobel
IFN-α inhibits HBV transcription and replication in cell culture and in humanized mice by targeting the epigenetic regulation of the nuclear cccDNA minichromosome
2012
Hepatocellular carcinoma
2022 Standout
Alpha-Interferon Suppresses Hepadnavirus Transcription by Altering Epigenetic Modification of cccDNA Minichromosomes
2013
ATP-Dependent Effector-like Functions of RIG-I-like Receptors
2015 StandoutNobel
Humanized mice efficiently engrafted with fetal hepatoblasts and syngeneic immune cells develop human monocytes and NK cells
2016 StandoutNobel
Development of Virus-Like Particle Technology from Small Highly Symmetric to Large Complex Virus-Like Particle Structures
2013 Standout
Hepatocellular Carcinoma
2019 Standout
AASLD guidelines for the treatment of hepatocellular carcinoma
2017 Standout
EASL 2017 Clinical Practice Guidelines on the management of hepatitis B virus infection
2017 Standout
Identification of Disubstituted Sulfonamide Compounds as Specific Inhibitors of Hepatitis B Virus Covalently Closed Circular DNA Formation
2012
Hepatocellular Carcinoma Incidence, Mortality, and Survival Trends in the United States From 1975 to 2005
2009 Standout
Modeling host interactions with hepatitis B virus using primary and induced pluripotent stem cell-derived hepatocellular systems
2014 StandoutNobel
Present and future therapies of hepatitis B: From discovery to cure
2015
Diagnosing COVID-19: The Disease and Tools for Detection
2020 Standout
New Parvovirus Associated with Serum Hepatitis in Horses after Inoculation of Common Biological Product
2018 StandoutNobel
COBAS AmpliPrep-COBAS TaqMan Hepatitis B Virus (HBV) Test: a Novel Automated Real-Time PCR Assay for Quantification of HBV DNA in Plasma
2007
Diagnosis, Staging, and Management of Hepatocellular Carcinoma: 2018 Practice Guidance by the American Association for the Study of Liver Diseases
2018 Standout
Zinc Finger Proteins Designed To Specifically Target Duck Hepatitis B Virus Covalently Closed Circular DNA Inhibit Viral Transcription in Tissue Culture
2008
Increased Susceptibility to DNA Virus Infection in Mice with a GCN2 Mutation
2011 StandoutNobel
Viral persistence, liver disease, and host response in a hepatitis C–like virus rat model
2017 StandoutNobel
EASL Clinical Practice Guidelines: Management of hepatocellular carcinoma
2018 Standout
Turmeric curcumin inhibits entry of all hepatitis C virus genotypes into human liver cells
2013 StandoutNobel
In vivo models of hepatitis B and C virus infection
2016
Current and Emerging Tools for Hepatocellular Carcinoma Surveillance
2021
Works of G. Raffa being referenced
Hepatitis B virus (HBV) induces the expression of interleukin-8 that in turn reduces HBV sensitivity to interferon-alpha
2013
The Characteristics of the Cell-Mediated Immune Response Identify Different Profiles of Occult Hepatitis B Virus Infection
2008
Hepatitis B virus DNA integration in tumour tissue of a non-cirrhotic HFE-haemochromatosis patient with hepatocellular carcinoma
2012
Hepatitis B virus maintains its pro-oncogenic properties in the case of occult HBV infection
2003
Hepatitis B Virus Replication Is Regulated by the Acetylation Status of Hepatitis B Virus cccDNA-Bound H3 and H4 Histones
2006
TT virus has a ubiquitous diffusion in human body tissues: analyses of paired serum and tissue samples
2003
PIVKA-II is a useful tool for diagnostic characterization of ultrasound-detected liver nodules in cirrhotic patients
2017
Molecular and functional analysis of occult hepatitis B virus isolates from patients with hepatocellular carcinoma
2007
Virological profiles in patients with chronic hepatitis C and overt or occult HBV infection
2002
Is investigation of hepatitis C virus NS5A gene heterogeneity a tool for predicting long‐lasting response to interferon therapy in patients with HCV‐1b chronic hepatitis?
2002
Impact of hepatitis B virus (HBV) preS/S genomic variability on HBV surface antigen and HBV DNA serum levels
2012
Analysis of haemochromatosis gene mutations in a population from the Mediterranean Basin
2001
Proliferation of primary human hepatocytes and prevention of hepatitis B virus reinfection efficiently deplete nuclear cccDNA in vivo
2017
Hepatitis B virus (HBV ) DNA integration in patients with occult HBV infection and hepatocellular carcinoma
2015
Replicative and Transcriptional Activities of Hepatitis B Virus in Patients Coinfected with Hepatitis B and Hepatitis Delta Viruses
2010
Nuclear HBx binds the HBV minichromosome and modifies the epigenetic regulation of cccDNA function
2009